1. Home
  2. HRMY vs NTCT Comparison

HRMY vs NTCT Comparison

Compare HRMY & NTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$41.14

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo NetScout Systems Inc.

NTCT

NetScout Systems Inc.

HOLD

Current Price

$39.17

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
NTCT
Founded
2017
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.7B
IPO Year
2020
1999

Fundamental Metrics

Financial Performance
Metric
HRMY
NTCT
Price
$41.14
$39.17
Analyst Decision
Buy
Buy
Analyst Count
9
2
Target Price
★ $44.11
$31.00
AVG Volume (30 Days)
★ 849.5K
545.0K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
7.97
★ 125.39
EPS
★ 1.84
0.29
Revenue
$868,453,000.00
★ $891,820,000.00
Revenue This Year
$19.75
$6.02
Revenue Next Year
$12.88
$2.55
P/E Ratio
★ $22.37
$135.34
Revenue Growth
★ 21.51
N/A
52 Week Low
$25.52
$25.20
52 Week High
$43.49
$45.28

Technical Indicators

Market Signals
Indicator
HRMY
NTCT
Relative Strength Index (RSI) 52.86 54.47
Support Level $40.92 $38.34
Resistance Level $43.38 $39.84
Average True Range (ATR) 1.21 0.84
MACD -0.27 0.24
Stochastic Oscillator 40.51 83.68

Price Performance

Historical Comparison
HRMY
NTCT

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About NTCT NetScout Systems Inc.

NetScout Systems Inc is engaged in providing enterprise network observability, carrier service assurance, cybersecurity, and Distributed Denial-of-Service (DDoS), protection solutions. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

Share on Social Networks: